BN Business News
Add your company to Business Communicator →

Business · 04/12/2012Updated: 10/17/2026 · 1 min read

FDA Releases Guidance on Oversight of Positron Emission Tomography (PET) Drug Products

Summary

The Food and Drug Administration (FDA) has published a guidance document addressing questions and answers regarding the agency's oversight of PET drug products, covering aspects such as application submission, review, and compliance with manufacturing practices.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →